Biotech Startups

Parsian Tarava manufactures needle-style reusable electrodes for electroporation applications in gene transfer and drug delivery across in vivo, ex vivo, and in ovo conditions. The electrodes are designed for use in research, biomedical, genetic, and pharmaceutical settings.

1 investor

1 investor

Persuasive develops a platform technology for high-throughput analysis of extracellular vesicles (EVs) and is building a blood-based diagnostic test using an EV protein biomarker signature to identify chronic coronary syndrome in primary-care patients presenting with chest pain. The company, spun out with UMC Utrecht researchers, targets early diagnosis of stable angina to reduce unnecessary hospital referrals.

1 investor

Petauri provides commercialization, market access, evidence generation, and strategic communications services to life sciences companies navigating the healthcare market. It helps clients demonstrate clinical and economic value and secure access with payers, health systems, and regulators.

1 investor

1 investor

Petrichor Capital Partners is a venture capital and private equity firm that invests in life sciences and biotech companies, with operations including a dedicated operating partner network and advisory board of scientific and medical experts.

1 investor

PexMachina develops physics-based molecular simulation for drug discovery, using quantum-ready computational chemistry and AI agents to predict properties like binding, stability, and oral availability of peptides. It delivers its PexAgent as an MCP service that integrates into LLM platforms such as Claude and Gemini, letting pharmaceutical researchers run molecular simulations via natural language within existing R&D workflows.

1 investor

Pexxes develops affordable biologic therapeutics for treating chronic diseases in dogs, cats, and horses. The company uses advanced antibody discovery technologies including phage display to create high-affinity binders for veterinary medicine applications.

1 investor

Peytant develops amnion-derived membrane coverings using human placental tissue to reduce the body's foreign body response in implants used for luminal disease treatment. The company's products are designed to increase patency and help clinicians manage vascular and other luminal conditions.

1 investor

Pfenex provides a Pseudomonas fluorescens-based microbial expression platform for manufacturing recombinant proteins, antibodies, and biologics at scale. The platform supports development from construct to production strain and enables technology transfer to CDMOs and manufacturing partners.

1 investor

pFIBRE makes flexible packaging films from wood pulp that are designed to biodegrade in seawater. The films are intended as a drop-in substitute for plastic film on existing packaging equipment, giving consumer brands a way to reduce microplastic pollution and address packaging regulations.

1 investor

Phanes Therapeutics develops oncology and metabolic disease therapeutics targeting cell cycle regulators and related pathways. The company operates from San Diego with operations including a research site in Shanghai.

1 investor

A contract drug manufacturing organization (CDMO) specializing in complex pharmaceutical formulations and potent compounds, serving drugmakers from small batches through full-scale production. The company holds FDA licensure and operates multiple manufacturing facilities with capabilities in oral dosage, aseptic processing, and analytical services.

1 investor

PharmaIN is a clinical-stage biopharmaceutical company developing peptide-based, subcutaneous self-injectable therapies through peptide engineering and drug delivery. Its pipeline targets advanced liver cirrhosis and cancer, including PHIN-214, a vasopressor therapy for decompensated cirrhosis in Phase 1 trials.

1 investor

PhmaPlanter develops biotechnology platforms for recombinant proteins, antibody development, gene editing, nutraceutical research, and advanced cellular technologies including gas vesicles and organoid culture systems.

1 investor

Pharmatest provides preclinical research services for drug development, including cell culture assays and animal models for cancer and skeletal disease research. The company serves pharmaceutical, biotechnology, and nutraceutical companies developing therapeutics and phytopharmaceutical products.

1 investor

Pharmatrophix is developing a small-molecule drug for Alzheimer's disease that acts upstream of amyloid, with Phase 2a trial imaging showing dose-dependent preservation of whole-brain connectivity. The company works in neurodegenerative disease drug development.

1 investor

Pharming is an integrated biotechnology company that develops and delivers targeted therapies for rare and ultra-rare immunological and genetic diseases, including hereditary angioedema (HAE), activated PI3K delta syndrome (APDS), and primary mitochondrial disease (PMD). It spans clinical development, manufacturing, regulatory affairs, and commercialization for the rare disease community.

1 investor

Pharos Bio builds Hydra, an autonomous AI platform that plans, runs, and validates bioinformatics analyses from a single prompt using preloaded databases and codified analysis skills. It also builds custom AI workflows deployed in-environment for SMB biotech and pharma teams working with proprietary omics and oncology data.

1 investor

PHASE Scientific develops diagnostic tools and technologies to improve health information accessibility and accuracy, with expertise in infectious disease prevention, dental health risk assessment, and bioengineering-based diagnostics.

1 investor

PhaseRx was a Seattle-based clinical-stage biopharmaceutical company developing mRNA-based intracellular enzyme replacement therapies for inherited liver enzyme deficiencies, initially targeting urea cycle disorders.

1 investor

Phastar is a biometrics and data science contract research organization serving pharmaceutical, biotech, and medical device companies. The firm uses data analytics, AI, and statistical expertise to accelerate clinical trial data management and regulatory approvals.

1 investor

PHC Corporation manufactures life sciences and diagnostic equipment, including ultra-low temperature freezers, CO2 incubators, live cell metabolic analyzers, and point-of-care testing devices for research, medical, and cell/gene therapy applications.

1 investor

PhenoTap develops KetoTap Core, a patent-pending BHB oxidase enzyme designed for reliable, affordable, real-time ketone measurement in blood test strips and continuous monitors. It offers the enzyme as a drop-in technology for device makers building glucose-style sensors, targeting continuous ketone monitoring for health and therapeutic applications.

1 investor